Yu et al. revealed that histone lactylation accelerated tumorigenesis through activating m6A reader protein, YTHDF2, indicating a potential target of histone lactylation for treating ocular melanoma (Yu et al., 2021). This evidence concerns the gene YTHDF2 and ocular melanoma.